Hellmich, Bernhard http://orcid.org/0000-0002-8014-1801
Buttgereit, Frank http://orcid.org/0000-0003-2534-550X
Article History
First Online: 3 September 2021
Competing interests
: B.H. declares receiving speaker fees and/or consultancy fees from Abbvie, AstraZeneca, Chugai, Novartis and Roche, and was convenor of the 2018 EULAR recommendations and the 2020 Deutsche Gesellschaft für Rheumatologie guideline for the management of large vessel vasculitis. F.B. declares receiving consultancy fees, honoraria and travel expenses from Galapagos, Horizon Therapeutics, Roche and Sanofi, and grant support from Horizon Therapeutics, Mundipharma, Roche and Sanofi. He has served as co-principal investigator and site investigator in a Mundipharma sponsored trial in polymyalgia rheumatica, and as principal investigator and site investigator in giant cell arteritis and polymyalgia rheumatica trials sponsored by Sanofi.